Pathogenesis, Assessments, and Management of Chemotherapy-Related Cognitive Impairment (CRCI)‎: An Updated Literature Review

Abstract EN

There are various cancer treatments at present, and chemotherapy is one of the main methods.

Chemotherapy-related cognitive impairment (CRCI), as one of the side effects of chemotherapy, has gradually attracted the attention of more and more researchers.

CRCI has been verified by subjective reports and objective neuropsychological tests so far.

But oncologists’ understanding of it and its treatments are still incomplete.

In this review, we mainly give a comprehensive overview of the mechanism of CRCI, then describe a variety of evaluation methods, and finally summarize the treatment approaches under current medical conditions and compare it with an excellent article published in 2015 with the aim of providing directions for future research and better understanding of CRCI for clinicians.